Are the vaccines safe? The inventor of mRNA vaccine technology says: "yet to be determined"

Dr Robert Malone started working with mRNA in the late '80s, with the intention of using it to cure genetic disorders. But he found the injected mRNA didn’t result in a huge number of proteins being made and they weren’t being widely distributed around the body. However, he realised that having cells make just a small amount of protein might be enough for an effective vaccine, as the body only needs a small amount to elicit an immune response.

Two of his big issues with the current Covid vaccines are:

1. the lack of safety data, due to the way they were rushed out, and

2. the fact that the pharmaceutical companies haven’t proved that the spike produced by the vaccine is less toxic that the ‘wild’ spike.

He firmly believes scientists should always assume danger from a new biological agent unless they can prove otherwise.

The Highwire, Ep.221 - 24th June 2021

Some excerpts:

On speaking with the FDA about spike protein risks:

“I was very aware of the biology of spike because it relates to one of the repurposed drugs that we’re working with, and I told them: ‘This isn’t just an antigen, this is a biologically active protein and it has effects’ - like modulating immune response and other things. It’s been treated as if it’s just an antigen, and it’s not.”

"These viruses pack all kinds of functional properties into their proteins and their genes because they have to have a very small and compact genome – it’s just the nature of RNA virus biology. So this is a biologically active protein that does more than just bind Ace2 (the receptor that is used by the virus to infect cells). And so I alerted them (in September 2020) – I said: ‘Are you aware of the implications of what’s being done here?’ - and they said ‘we don’t see that as a problem and we’re not going to worry about it’.”

---

“The new synthetic lipid…which is really enabling for these current generation vaccines, has never been in humans in large scale. And the data packet from Pfizer shows that this particular lipid accumulates at high concentration in the ovaries. That’s very odd. We don’t know for sure what the effects are going to be of the lipid delivery package.”

“So, when you say to me, ‘Are you sure that this is gonna be safe?’ - the general concept, yeah. This specific compound: to be determined.”

“I think, to be responsible, we need to disclose to the public completely what these potential risks are. I think that’s fundamental, bedrock bioethics. And the public needs to understand these pharmacodistribution studies that were done and needs to be aware that the full reproductive toxicology package was not performed before they started being administered.”

---

“I can’t say whether the risk/benefit ratio makes sense or not because I don’t think they’re following protocol and actually calculating the risk/benefit ratio. So, risk/benefit for pregnant women, for adolescents, the elderly – all those things have to be calculated and they don’t have the data.”

---

“One of the things about ad vector gene therapy technology is it was designed to provide long-term expression of the trans gene – that’s a fancy way of saying it makes a lot of protein for a long time. How much protein? There is no assessment of what the levels or duration of expression are in tissue."

"In their wisdom, the FDA has decided not to require that the pharmaceutical companies characterise exactly how much spike protein is being made. We don’t know. And it is reasonable to assume, based on everything I know, that the adenoviral vectors may be expressing significantly more protein for a longer duration than the mRNA. So, no surprise that the safety signal for coagulopathy pops up first with the ad vector vaccines. That doesn’t mean that’s not going to happen with the RNA vaccines.”

---

“The FDA is no longer independent of political pressure and that is a big problem.”

---

Dr Robert Malone’s mRNA story, by his wife, Dr Jill Glasspool-Malone